Handbook of polymers for pharmaceutical technologies : volume 3, biodegradable polymers

Content: Half Title page
 Title page
 Copyright page
 Dedication
 Preface
 Chapter 1: Bioactive Polysaccharides of Vegetable and Microbial Origins: An Overview
 1.1 Introduction
 1.2 Anticarcinogenic Polysaccharides
 1.3 Anti-inflammatory/Immunostimulating Polysaccharides
 1.4 Antiviral Polysaccharides
 1.5 Antioxidant Polysaccharides
 1.6 Other Biotechnological Applications
 1.7 Conclusions and Future Perspectives
 Acknowledgments
 References
 Chapter 2: Chitosan: An Emanating Polymeric Carrier for Drug Delivery
 2.1 Introduction
 2.2 Preparation of Chitosan 2.3 Physicochemical Properties of Chitosan2.4 Biological Activities of Chitosan
 2.5 Pharmaceutical Applications of Chitosan
 2.6 Functionalization of Chitosan
 2.7 Conclusion and Future Perspectives
 References
 Chapter 3: Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications
 3.1 Introduction
 3.2 The Fungal Cell
 3.3 Polysaccharides Produced by Fungi
 3.4 Production and Extraction of Polysaccharides from Fungi
 3.5 Fungal Polysaccharides in Biomedical and Pharmaceutical Applications 3.6 Commercial Exploitation of Fungal Polysaccharides in Biomedical and Pharmaceutical Applications3.7 Conclusion and Future Perspective
 References
 Chapter 4: Environmentally Responsive Chitosan-based Nanocarriers (CBNs)
 4.1 Introduction
 4.2 Graft Copolymerized CBNs
 4.3 pH-Sensitive CBNs
 4.4 Thermosensitive CBNs
 4.5 pH-Sensitive and Thermosensitive CBNs
 4.6 pH- and Ionic-Sensitive CBNs
 4.7 Photosensitive CBNs
 4.8 Electrical-Sensitive CBNs
 4.9 Magneto-Responsive CBNs
 4.10 Chemo-Sensitive CBNs
 4.11 Biodegradation of Chitosan and Its Derivatives
 4.12 Toxicity of CBNs 4.13 Conclusions and Future PerspectivesReferences
 Chapter 5: Biomass Derived and Biomass Inspired Polymers in Pharmaceutical Applications
 5.1 Introduction
 5.2 Biodegradable Polymers in Biomedical Applications --
Relevant Aspects
 5.3 Biodegradable Natural Polymers in Pharmaceutical Applications
 5.4 Micro- and Nanocrystalline Natural Polymers and Fibrils --
General Regulative Considerations
 5.5 Concluding Remarks and Outlook
 References
 Chapter 6: Modification of Cyclodextrin for Improvement of Complexation and Formulation Properties
 Abbrevations:
 6.1 Introduction 6.2 Cyclodextrin and Its Degradation6.3 Complexation by CDs and Release
 6.4 Modifications and Scope with Respect to Pharmaceutical Application
 6.5 Concluding Remarks
 Acknowledgements
 References
 Chapter 7: Cellulose-, Ethylene Oxide- and Acrylic-Based Polymers in Assembled Module Technology (Dome Matrix®)
 7.1 Dome Matrix® Technology
 7.2 Polymers for Controlled Drug Release
 7.3 Cellulose Derivatives
 7.4 Acrylic Acid Polymers
 7.5 Polymethacrylates
 7.6 Polyethylene Oxide
 7.7 Conclusions
 Acknowledgments
 References
 Chapter 8: Structured Biodegradable Polymers for Drug Delivery